Immediate Impact
8 from Science/Nature 56 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Mitochondria at the crossroads of health and disease
2024 Standout
Works of Tze‐Yi Lin being referenced
IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy
2016
ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tze‐Yi Lin | 560 | 140 | 177 | 184 | 52 | 1.3k | |
| Licheng Dai | 697 | 105 | 148 | 230 | 55 | 1.2k | |
| Ashis K. Mondal | 840 | 138 | 178 | 316 | 72 | 1.7k | |
| Xavier Havaux | 482 | 75 | 239 | 182 | 52 | 1.5k | |
| D. B. v. Bassewitz | 321 | 168 | 181 | 166 | 46 | 1.1k | |
| Yi Zhou | 652 | 216 | 165 | 246 | 50 | 1.5k | |
| John H. Peters | 473 | 161 | 118 | 223 | 68 | 1.6k | |
| Neşe Atabey | 805 | 284 | 198 | 323 | 58 | 1.5k | |
| Eleni Mylona | 677 | 357 | 144 | 177 | 43 | 1.4k | |
| Patrice M. Becker | 471 | 107 | 132 | 91 | 46 | 1.3k | |
| Yan Li | 811 | 233 | 174 | 282 | 54 | 1.5k |
All Works
Loading papers...